CONTINENTAL GRAIN CO - 24 Jul 2023 Form 4 Insider Report for GreenLight Biosciences Holdings, PBC

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
26 Jul 2023, 16:02:33 UTC
Prior SEC filing
08 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Continental Grain Company, /s/ David Dryerman, SVP - Finance and Treasurer

Key filing fact

CONTINENTAL GRAIN CO filed Form 4 for GreenLight Biosciences Holdings, PBC on 26 Jul 2023.

Key facts

  • This page summarizes CONTINENTAL GRAIN CO's Form 4 filing for GreenLight Biosciences Holdings, PBC.
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 26 Jul 2023, 16:02.

Change

  • Previous filing in this sequence was filed on 08 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GRNA transaction

Greenlight Biosciences common stock

Other

Transaction value
Shares
-6,489,242
Change %
-100%
Price
Shares after
0
Date
24 Jul 2023
Ownership
See Footnote
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

CONTINENTAL GRAIN CO is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

On July 24, 2023, pursuant to the Contribution and Exchange Agreement between the Reporting Persons and SW ParentCo, Inc. ("Parent"), the Reporting Persons disposed of all previously reported shares of Common Stock in exchange for shares of Series A-2 Preferred Stock, par value $0.001 per share, of Parent in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger among Issuer, Parent and SW MergerCo, Inc. ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer, and the Reporting Persons ceased to beneficially own shares of Common Stock.

Footnote F2

Prior to the reported transactions, Continental Grain Company ("Continental Grain") directly held 2,387,044 shares of Common Stock and Conti Greenlight Investors, L.P. ("Conti Greenlight Investors") directly held 4,102,198 shares of Greenlight Biosciences common stock ("Common Stock"). The general partner of Conti Greenlight Investors is Conti Greenlight, LLC ("Conti Greenlight"). The managing member of Conti Greenlight is Continental Grain. Accordingly, Continental Grain may be deemed to beneficially own the shares of Common Stock held directly by Conti Greenlight Investors. Each reporting person disclaims beneficial ownership of the reported securities, except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .